Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antiphospholipid antibodies.

Cristina Tanaseanu1, Elena Moldoveanu, St Tanaseanu

  • 1Emergency Hospital St. Pantelimon, Department of Internal Medicine, Bucharest, Romania.

Haematologia
|June 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human cardiac telocytes: 3D imaging by FIB-SEM tomography.

Journal of cellular and molecular medicine·2014
Same author

Dynamics of telopodes (telocyte prolongations) in cell culture depends on extracellular matrix protein.

Molecular and cellular biochemistry·2014
Same author

Objective assessment of image quality and dose reduction in CT iterative reconstruction.

Medical physics·2014
Same author

Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties.

Journal of materials science. Materials in medicine·2013
Same author

Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts.

Journal of cellular and molecular medicine·2013
Same author

Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum.

Histology and histopathology·2012

Antiphospholipid antibodies (APLAs) are linked to clotting disorders. Assays for APLAs like anticardiolipin antibodies (aCLAs) and lupus anticoagulant (LA) are crucial for identifying hypercoagulability risks in various diseases.

Area of Science:

  • Immunology
  • Hematology
  • Pathology

Background:

  • Antiphospholipid antibodies (APLAs) are autoantibodies targeting phospholipids and their protein cofactors.
  • APLA presence is associated with hypercoagulability and thromboembolic events.
  • APLAs are implicated in diverse conditions including autoimmune diseases, infections, and malignancies.

Purpose of the Study:

  • To characterize specific APLAs: anticardiolipin antibodies (aCLAs), lupus anticoagulant (LA), and anti-beta2-glycoprotein I antibodies (anti-beta2-GPIAs).
  • To elucidate the mechanisms of APLA action and their interactions with cellular components.
  • To explore the clinical relevance of APLAs in various disease states.

Main Methods:

  • Review of existing literature on APLA characteristics and functions.

Related Experiment Videos

  • Analysis of APLA interactions with anionic phospholipid-protein cofactors.
  • Examination of cellular interactions involving blood and endothelial cells.

    • Main Results:

    • APLAs, including aCLAs, LA, and anti-beta2-GPIAs, contribute to a hypercoagulable state.
    • These antibodies mediate thromboembolic events through complex interactions.
    • APLA detection is relevant across autoimmune diseases, atherosclerosis, infections, and malignancies, often correlating with disease severity.

    Conclusions:

    • Assays for APLAs are essential for diagnosing and managing hypercoagulability syndromes.
    • Understanding APLA mechanisms provides insight into their role in diverse pathologies.
    • APLA detection aids in predicting disease progression and patient outcomes.